- VernacularTitle:2025年版《中国药典》二部主要增修订内容解读
- Author:
Yi ZHOU
1
;
Zhijun WANG
1
;
Zhihua YUE
1
;
Qilei CHENG
1
;
Ruiqi YUE
1
;
Xi YANG
1
;
Wei GUO
1
;
Shuangcheng MA
1
Author Information
- Publication Type:Journal Article
- Keywords: The Chinese Pharmacopoeia 2025 Edition(Volume Ⅱ)(ChP 2025,Volume Ⅱ); the addition and revision of drug monographs; drug standard
- From: Drug Standards of China 2025;26(1):23-27
- CountryChina
- Language:Chinese
- Abstract: The Pharmacopeia of the People's Republic of China 2025 Edition(referred to as the Chinese Pharmaco-poeia 2025 Edition,ChP 2025)will be promulgated and implemented.This article introduces the process of devel-opment of ChP 2025 Edition(Volume Ⅱ),including the selection,the revision of general notices,the addition and revision of drug monographs,etc.,and provides some analysis and examples to illustrate,which can facilitate the readers to understand and implement the ChP 2025 Edition(Volume Ⅱ).

